MockingbirdNews Logo

Mockingbird News

REAL NEWS NEVER FELT FUNNIER

Categories

The Gyst
Loading...

Stealth BioTherapeutics Plans Exit After FDA Sends Mixed Signals

Stealth BioTherapeutics Plans Exit After FDA Sends Mixed Signals
Photo by CDC on Unsplash

Stealth BioTherapeutics, the biotech equivalent of a cautious cat, is prepping to shut down after receiving what it called 'conflicting' signals from the FDA. It’s like getting a yes, no, maybe so, and ¯\_(ツ)_/¯ all in one letter. Developing a rare disease drug isn’t for the faint of heart, but apparently trying to decode FDA feedback is a full-contact sport. The company said it's making 'contingency plans to close,' proving sometimes the biggest rare disease is surviving bureaucracy without a sequel to your disaster.

Share the Story

(1 of 3)
Swipe to navigate

Source: Statnews | Published: 8/5/2025 | Author: Ed Silverman